Related Experiment Video
Updated: Jun 16, 2025

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
Unveiling the enigma: A challenging case of protein C deficiency concealed by fever and epistaxis
Iman Jauhar1, Muhammad Mubashir1, Muhammad Shehryar Wahla2
1Department of Medicine, Liaquat National Hospital and Medical College, Karachi, Pakistan.
Insights
Protein C deficiency, a rare genetic disorder, increases blood clot risk. Early diagnosis and lifelong anticoagulation are vital for managing venous thromboembolism complications in young patients.
Area of Science:
- Genetics
- Hematology
- Vascular Medicine
Background:
- Protein C deficiency is a rare inherited thrombophilia affecting 1 in 200-500 individuals.
- Caused by mutations in the F5 gene, it leads to a hypercoagulable state and increased risk of thrombosis.
- Clinical manifestations range from neonatal purpura fulminans to adult venous thromboembolism (VTE).
Observation:
- A 21-year-old South Asian male presented with symptoms suggestive of deep vein thrombosis (DVT).
- Diagnostic tests confirmed extensive DVT in the legs and a pulmonary embolism (PE).
- The patient was diagnosed with protein C deficiency.
Findings:
- The patient received anticoagulant therapy, thrombolysis, and an inferior vena cava filter for extensive DVT and PE.
- Complications of protein C deficiency include DVT, PE, stroke, and ischemic colitis.
- Diagnosis relies on immunoassays and genetic analysis, with lifelong anticoagulation often required.
Implications:
- This case highlights the critical need for early diagnosis and management of protein C deficiency in young VTE patients.
- Prompt treatment, including anticoagulation and potentially an IVC filter, is essential to prevent severe complications.
- Lifelong anticoagulation therapy is crucial for managing protein C deficiency and preventing recurrent thrombotic events.
Abstract:
Protein C deficiency is a rare genetic disorder caused by mutations in the protein C, inactivator of coagulation factors Va and VIIA gene, affecting approximately 1 in 200-500 individuals. It leads to a hypercoagulable state, increasing the risk of blood clots. Symptoms vary with age, ranging from life-threatening purpura fulminans in neonates to venous thromboembolism, particularly deep vein thrombosis, in adults. A recent case involved a 21-year-old South Asian male presenting with persistent fever, weight loss, epistaxis, abdominal tenderness, and acute pain in the right thigh and leg, raising suspicion of deep vein thrombosis. Tests confirmed deep vein thrombosis in multiple leg veins and a pulmonary embolism. The patient was diagnosed with protein C deficiency and received anticoagulant therapy, thrombolysis, and an inferior vena cava filter. Complications of protein C deficiency include deep vein thrombosis, pulmonary embolism, stroke, and ischemic colitis. Diagnosis involves immunoassays and genetic analysis. Treatment includes heparin followed by anticoagulation therapy with warfarin. In severe cases, an inferior vena cava filter may be implanted. The described case required extensive treatment due to multiple deep vein thrombosis and a pulmonary embolism, with lifelong anticoagulant therapy. Early diagnosis and appropriate management are crucial in young patients with a history of venous thromboembolism to prevent and manage complications associated with protein C deficiency.
Related Concept Videos
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Epistaxis
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
Cystic Fibrosis: Management
Sinus disease and chronic...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Pneumonia III: Complications and Assessment

